Hope Not Hype - Third World Network
Hope Not Hype - Third World Network
Hope Not Hype - Third World Network
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Appendix One: What is a GMO<br />
139<br />
Therefore, heritability is sufficient but not necessary as evidence to establish the<br />
need for a risk assessment, and exposure to modified nucleic acids is sufficient to conclude<br />
that an organism is genetically modified. It would not appear to be appropriate to counsel<br />
potential applicants that the use of rDNA that “did not replicate or recombine” is exempt<br />
from the legal requirement of an ERMA risk assessment.<br />
RNA is genetic material but not always “heritable”<br />
DNA may modify the genes or other material of an organism without being heritable,<br />
as described above. There is no reason a priori to believe that this would be a characteristic<br />
unique to DNA. Many of the above examples could be recreated by re-introducing the<br />
mRNA molecule in place of the DNA molecule. Thus, ERMA’s determination as to the<br />
intent of lawmakers would also make clear that all organisms modified by exposure to<br />
RNA should be considered GMOs and require an ERMA risk assessment (ERMA, 2006,<br />
p. 44). However, the use of in vitro synthesized dsRNA, or dsRNA isolated from an<br />
organism and then re-introduced into a recipient organism would presumably not be subject<br />
to regulatory oversight as long as ERMA retained its policy (ERMA, 2006). In so doing,<br />
the policy makes this application of RNA distinct from equivalent treatments using DNA.<br />
The only way that can be done is to assume that: (1) RNA is not genetic material, (2) gene<br />
silencing is not a heritable trait or character, and/or (3) the instigating dsRNA, amplified<br />
or persistent, or chromatin modifications/DNA/histone methylation that maintain the effect,<br />
are not the product of replication.<br />
The use of dsRNA in genetic engineering is growing (Ivashuta et al., 2008). Though<br />
unintended, it appears in retrospect to be behind the trait in the now defunct FlavrSavr<br />
tomato first produced by Calgene (Ivashuta et al., 2008; Sanders and Hiatt, 2005). dsRNA<br />
is the basis of pre-commercial research to develop caffeine-free coffee through gene<br />
silencing (Ogita et al., 2003) and the basis for viral resistance in papaya (Tennant et al.,<br />
2001). dsRNA has been intentionally tested as an insecticide (Baum et al., 2007; Mao et<br />
al., 2007). The researchers demonstrated that dsRNA produced by transgenes in plants<br />
can be infectiously transferred through food to gut cells in insects, and subsequently spread<br />
within the animals separately from the rDNA (Gordon and Waterhouse, 2007). In contrast<br />
perhaps with the New Zealand regulator, the Monsanto Company declared that<br />
“[e]stablishing a well-documented history of safe consumption for RNA molecules<br />
including those that mediate RNAi (e.g. miRNAs and siRNAs) will be an important<br />
component of this weight of evidence approach for evaluating the safety of crop products<br />
developed utilizing RNAi-mediated gene suppression” (Monsanto study published under<br />
Ivashuta et al., 2008).<br />
Conclusions<br />
From the above discussion it is clear that RNA is unambiguously among the materials<br />
that through in vitro modification would create a GMO as defined by the HSNO Act.<br />
Meanwhile, decisions on whether particular applications of RNA or DNA (where they are